These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 16443424)
1. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Gauri AJ; Davis A; Hong T; Burke MC; Knight BP Am J Med; 2006 Feb; 119(2):167.e17-21. PubMed ID: 16443424 [TBL] [Abstract][Full Text] [Related]
2. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of Thomas KL; Al-Khatib SM; Kelsey RC; Bush H; Brosius L; Velazquez EJ; Peterson ED; Gilliam FR Am J Cardiol; 2007 Sep; 100(6):924-9. PubMed ID: 17826371 [TBL] [Abstract][Full Text] [Related]
3. Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). Zhang Y; Kennedy R; Blasco-Colmenares E; Butcher B; Norgard S; Eldadah Z; Dickfeld T; Ellenbogen KA; Marine JE; Guallar E; Tomaselli GF; Cheng A Heart Rhythm; 2014 Aug; 11(8):1377-83. PubMed ID: 24793459 [TBL] [Abstract][Full Text] [Related]
4. Women and minorities are less likely to receive an implantable cardioverter defibrillator for primary prevention of sudden cardiac death. Mezu U; Ch I; Halder I; London B; Saba S Europace; 2012 Mar; 14(3):341-4. PubMed ID: 22071382 [TBL] [Abstract][Full Text] [Related]
5. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
6. Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-Are there predictors of appropriate therapy? Weissler-Snir A; Dorian P; Rakowski H; Care M; Spears D Heart Rhythm; 2021 Jan; 18(1):63-70. PubMed ID: 32800967 [TBL] [Abstract][Full Text] [Related]
7. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Hoang A; Shen C; Zheng J; Taylor S; Groh WJ; Rosenman M; Buxton AE; Chen PS Heart Rhythm; 2014 May; 11(5):849-55. PubMed ID: 24566233 [TBL] [Abstract][Full Text] [Related]
8. Implantable cardioverter defibrillator and survival after out-of-hospital cardiac arrest due to acute myocardial infarction in Denmark in the years 2001-2012, a nationwide study. Winther-Jensen M; Kjaergaard J; Lassen JF; Køber L; Torp-Pedersen C; Hansen SM; Lippert F; Kragholm K; Christensen EF; Hassager C Eur Heart J Acute Cardiovasc Care; 2017 Mar; 6(2):144-154. PubMed ID: 28058848 [TBL] [Abstract][Full Text] [Related]
9. Impact of Chronic Total Coronary Occlusion on Recurrence of Ventricular Arrhythmias in Ischemic Secondary Prevention Implantable Cardioverter-Defibrillator Recipients (VACTO Secondary Study): Insights From Coronary Angiogram and Electrogram Analysis. Nombela-Franco L; Iannaccone M; Anguera I; Amat-Santos IJ; Sanchez-Garcia M; Bautista D; Calvelo MN; Di Marco A; Moretti C; Pozzi R; Scaglione M; Cañadas V; Sandin-Fuentes M; Arenal A; Bagur R; Perez-Castellano N; Fernandez-Perez C; Gaita F; Macaya C; Escaned J; Fernández-Lozano I JACC Cardiovasc Interv; 2017 May; 10(9):879-888. PubMed ID: 28473110 [TBL] [Abstract][Full Text] [Related]
10. Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial. Jackson LR; McKenna K; Corneli A; Dombeck C; Brelsford K; Thomas KL Circ Cardiovasc Qual Outcomes; 2024 Jul; 17(7):e010550. PubMed ID: 38864226 [TBL] [Abstract][Full Text] [Related]
11. Referral Patterns for Primary Prophylaxis Implantable Cardioverter Defibrillator Therapy for an Urban US Population. Manheimer ED; Gonzalez C; Turk J; Krumerman AK; Kim SG; Gross JN; Palma EC; Grushko MJ; Fisher JD; Ferrick KJ Am J Cardiol; 2015 Oct; 116(8):1210-2. PubMed ID: 26320756 [TBL] [Abstract][Full Text] [Related]
12. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy. Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359 [TBL] [Abstract][Full Text] [Related]
15. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD). Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death. Kreuz J; Skowasch D; Horlbeck F; Atzinger C; Schrickel JW; Lorenzen H; Nickenig G; Schwab JO Am J Cardiol; 2013 May; 111(9):1319-23. PubMed ID: 23411108 [TBL] [Abstract][Full Text] [Related]
18. Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. Curtis LH; Al-Khatib SM; Shea AM; Hammill BG; Hernandez AF; Schulman KA JAMA; 2007 Oct; 298(13):1517-24. PubMed ID: 17911496 [TBL] [Abstract][Full Text] [Related]
19. Sex differences in implantable cardioverter-defibrillator implantation indications and outcomes: lessons from the Nationwide Israeli-ICD Registry. Amit G; Suleiman M; Konstantino Y; Luria D; Kazatsker M; Chetboun I; Haim M; Gavrielov-Yusim N; Goldenberg I; Glikson M; Europace; 2014 Aug; 16(8):1175-80. PubMed ID: 24554524 [TBL] [Abstract][Full Text] [Related]
20. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use. Pillarisetti J; Kondur A; Alani A; Reddy M; Reddy M; Vacek J; Weiner CP; Ellerbeck E; Schreiber T; Lakkireddy D J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2831-9. PubMed ID: 24814494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]